血管内皮生长因子C(VEGFC)真核蛋白
Eukaryotic Vascular Endothelial Growth Factor C (VEGFC)
VEGF-C; Flt4-L; VRPL; Vascular Endothelial Growth Factor-Related Protein
- 编号EPA145Mu61
- 物种Mus musculus (Mouse，小鼠)相同的名称，不同的物种。
- 来源真核表达
- 宿主293F cell
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位分泌
- 预测分子量14.7kDa
- 实际分子量15&18kDa(差异分析请参阅说明书)
- 片段与标签Ala108~Arg223 with N-terminal His Tag
- 缓冲液成份PBS, pH7.4, containing 5% Trehalose.
- 性状冻干粉
- 纯度> 90%
- 等电点8.5
- 应用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，请参见活性蛋白。 - 下载英文说明书 中文说明书
- 规格10µg50µg200µg1mg5mg
- 价格¥ 984¥ 2460¥ 4920¥ 14760¥ 36900
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
产品包装(模拟)
产品包装(模拟)
Figure. SDS-PAGE
通过ISO 9001、ISO 13485质量体系认证
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月，-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
增值服务
相关产品
| 编号 | 适用物种：Mus musculus (Mouse，小鼠) | 应用(仅供研究使用，不用于临床诊断！) |
| RPA145Mu01 | 血管内皮生长因子C(VEGFC)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPA145Mu61 | 血管内皮生长因子C(VEGFC)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA145Mu01 | 血管内皮生长因子C(VEGFC)多克隆抗体 | WB |
| PAA145Mu02 | 血管内皮生长因子C(VEGFC)多克隆抗体 | WB; IHC; ICC; IP. |
| LAA145Mu81 | 血管内皮生长因子C(VEGFC)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
| LAA145Mu71 | 血管内皮生长因子C(VEGFC)多克隆抗体(生物素标记) | WB; IHC; ICC. |
| MAA145Mu21 | 血管内皮生长因子C(VEGFC)单克隆抗体 | WB |
| LAA145Mu72 | 血管内皮生长因子C(VEGFC)单克隆抗体(生物素标记) | WB; IHC; ICC. |
| SEA145Mu | 血管内皮生长因子C(VEGFC)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| MEA145Mu | 血管内皮生长因子C(VEGFC)检测试剂盒(酶联免疫吸附试验法,小样本) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA145Mu | 血管内皮生长因子C(VEGFC)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
| PSA145Mu01 | 血管内皮生长因子C(VEGFC)抗体对 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| KSA145Mu01 | 血管内皮生长因子C(VEGFC)检测试剂盒DIY材料(酶联免疫吸附试验法) | 自己动手制作ELISA试剂盒的主要材料 |
参考文献
| 杂志 | 参考文献 |
| Journal of Cellular Biochemistry | Alternatively activated RAW264. 7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma[PubMed: 19241443] |
| genetics and molecular research | Expression of COX-2 and VEGF-C in cholangiocarcinomas at different clinical and pathological stages[PubMed: 26125824] |
| Experimental and Therapeutic | Fenofibrate inhibits the expression of VEGFC and VEGFR-3 in retinal pigmental epithelial cells exposed to hypoxia[PubMed: 26622498] |
| Am J Pathol | IL-10 Indirectly Regulates Corneal Lymphangiogenesis and Resolution of Inflammation via Macrophages[PubMed: 26608451] |
| PLoS One. | Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells.[pubmed:27383632] |
| Oncology Letters | RNAi-mediated gene silencing of vascular endothelial growth factor C suppresses growth andinduces apoptosis in mouse breast cancer in vitro and in vivo.[pubmed:27895746] |
| Angiogenesis | Characterization of isolated liver sinusoidal endothelial cells for liver bioengineering[Pubmed:29582235] |
| Oncology Reports | Effects of diphyllin as a novel V-ATPase inhibitor on TE-1 and ECA-109 cells[Pubmed:29328465] |
| LABORATORY INVESTIGATION | Dynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease[Pubmed: 31019289] |
| Cutaneous and Ocular Toxicology | Isotretinoin does not alter VEGF-A and VEGF-C levels: Do retinoids behave differently in dose-dependent and/or in vivo/in vitro conditions?[Pubmed: 32722957] |